Cover Image
市場調查報告書

玻尿酸(HA)的全球市場

Global Hyaluronic Acid (HA) Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 317295
出版日期 內容資訊 英文 86 Pages
訂單完成後即時交付
價格
Back to Top
玻尿酸(HA)的全球市場 Global Hyaluronic Acid (HA) Market 2014-2018
出版日期: 2014年10月22日 內容資訊: 英文 86 Pages
簡介

玻尿酸(HA)骨關節炎的潤滑補助劑,廣用於眼科疾病用,VUR (膀胱輸尿管逆流症)用,還有皮膚填充用等醫療用途,HA的全球市場從2013年到2018年5年間預計以9.14%的CAGR持續成長。

本報告以全球HA市場為主題,提供由許多產業專家取得的資料、資訊,以及推動市場成長要素、市場課題、市場趨勢,還有依據市場競爭情形詳細分析導出市場規模與未來預測。並且提供該市場主要企業相關之,包含商務、策略,及最近企業發展分析的詳細企業簡介。

第1章 摘要整理

第2章 簡稱表

第3章 本報告涵蓋範圍

  • 市場概要
  • 提供產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 序論

第6章 市場情形

  • HA製造流程
  • 市場概要

第7章 HA全球市場

  • 市場規模及未來預測
  • 波特的五力分析

第8章 各用途市場分析

  • 各用途HA全球市場分析
  • 皮膚填充劑用HA全球市場
    • 市場規模及未來預測
  • 骨關節炎治療用HA全球市場
    • 市場規模及未來預測
  • VUR (膀胱輸尿管逆流症)治療用HA全球市場
    • 市場規模及未來預測
  • 眼科治療用HA全球市場
    • 市場規模及未來預測

第9章 各產品市場分析

  • 各產品HA全球市場分析
  • 1次注射週期用HA產品全球市場
    • 市場規模及未來預測
  • 3次注射週期用HA產品全球市場
    • 市場規模及未來預測
  • 5次注射週期用HA產品全球市場
    • 市場規模及未來預測

第10章 各地區市場分析

  • 各地區的HA全球市場
  • 北美HA市場
    • 市場規模及未來預測
  • 歐洲HA市場
    • 市場規模及未來預測
  • 亞太地區HA市場
    • 市場規模及未來預測
  • 其他地區的HA市場
    • 市場規模及未來預測

第11章 主要國家

  • 美國
  • 法國
  • 日本

第12章 購買標準

第13章 推動市場成長要素

第14章 推動市場成長要素與其影響

第15章 市場課題

第16章 市場成長促進要素和市場課題帶來的影響

第17章 市場趨勢

第18章 市場趨勢與其影響

第19章 供應商情形

  • 市場競爭方案
  • 其他重要供應商

第20章 主要供應商分析

  • Allergan Inc.
  • Ferring Pharmaceuticals
  • Fidia Farmaceutici
  • Sanofi
  • 生化學工業株式會社

第21章 相關報告

目錄
Product Code: IRTNTR4430

About Hyaluronic Acid

Hyaluronic acid (HA) or glass acid is a naturally occurring non-sulfated glycosaminoglycan. It is present in the human body in the joints, eye cavity, and internal defense systems. It functions as a nutrient carrier, along with helping the tissues in retaining water. It is an integral part of the extracellular matrix and is found in the coverings around chondrocytes. HA is produced commercially by various processes, including extraction from animal tissues, bacterial production, and in-vitro production. Its major medical applications are viscosupplementation for osteoarthritis, ophthalmic, VUR, and dermal fillers. HA is commercially available in the form of single-injection cycle HA products, three-injection cycle HA products, and five-injection cycle HA products.

TechNavio's analysts forecast the Global HA Market will grow at a CAGR of 9.14 percent over the period 2013-2018.

Covered in this Report

The Global HA market can be divided on the basis of application into the following segments: Dermal Fillers, Osteoarthritis, Ophthalmic, and VUR.

TechNavio's report, the Global HA Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, the APAC region, and the ROW; it also covers the Global HA Market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • North America
  • Europe
  • APAC
  • ROW

Key Vendors

  • Allergan
  • Ferring Pharmaceuticals
  • Fidia Farmaceutici
  • Sanofi
  • Seikagaku

Other Prominent Vendors

  • Abbott Medical Optics
  • Abdi Ibrahim
  • Alcon
  • Alveda
  • Angelini
  • Anika Therapeutics
  • AstraZeneca
  • Bausch & Lomb
  • Bayer
  • Biomet
  • Bioniche Teoranta
  • Boustead Group of Companies
  • Bruschettini
  • Cadila Healthcare
  • Choseido Pharmaceutical
  • Contipro Biotech
  • Daiichi-Sankyo
  • Documedica
  • Expanscience
  • F. Hoffmann-La Roche
  • Galderma
  • Genzyme
  • HTL Biotechnology
  • Hyaltech
  • Lifecore Biomedical
  • Lipo Chemicals
  • Meiji Seika Pharma
  • Merz Aesthetics
  • Nordic Drugs
  • Novozymes
  • Salix Pharmaceuticals
  • Shandong Freda Biochem
  • Shanghai Jingfeng Pharmaceutical
  • Smith & Nephew
  • Teijin Pharma
  • TRB Chemedica International
  • Zimmer Holdings

Key Market Driver

  • Rise in Geriatric Population
  • For a full, detailed list, view our report

Key Market Challenge

  • Threat of Substitution for Osteoarthritis
  • For a full, detailed list, view our report

Key Market Trend

  • Shift in Consumer Preference for Single-Injection Cycle HA Products
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. HA Production Process
  • 06.2. Market Overview

07. Global HA Market

  • 07.1. Market Size and Forecast
  • 07.2. Five Forces Analysis

08. Market Segmentation by Application

  • 08.1. Global HA Market Segmentation by Application 2013-2018
  • 08.2. Global HA Market in Dermal Fillers
    • 08.2.1. Market Size and Forecast
  • 08.3. Global HA Market for Osteoarthritis
    • 08.3.1. Market Size and Forecast
  • 08.4. Global HA Market for VUR
    • 08.4.1. Market Size and Forecast
  • 08.5. Global HA Market in Ophthalmic
    • 08.5.1. Market Size and Forecast

09. Market Segmentation by Product

  • 09.1. Global HA Market Segmentation by Product 2013-2018
  • 09.2. Global Single-Injection Cycle HA Products Market
    • 09.2.1. Market Size and Forecast
  • 09.3. Global Three-Injection Cycle HA Products Market
    • 09.3.1. Market Size and Forecast
  • 09.4. Global Five-Injection Cycle HA Products Market
    • 09.4.1. Market Size and Forecast

10. Geographical Segmentation

  • 10.1. Global HA Market Segmentation by Geography 2013-2018
  • 10.2. HA Market in North America
    • 10.2.1. Market Size and Forecast
  • 10.3. HA Market in Europe
    • 10.3.1. Market Size and Forecast
  • 10.4. HA Market in the APAC Region
    • 10.4.1. Market Size and Forecast
  • 10.5. HA Market in ROW
    • 10.5.1. Market Size and Forecast

11. Key Leading Countries

  • 11.1. US
  • 11.2. France
  • 11.3. Japan

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
  • 19.2. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Allergan Inc.
    • 20.1.1. Key Facts
    • 20.1.2. Business Description
    • 20.1.3. Business Segmentation
    • 20.1.4. Revenue by Business Segmentation
    • 20.1.5. Revenue Comparison 2011-2013
    • 20.1.6. Revenue by Geographical Segmentation
    • 20.1.7. Business Strategy
    • 20.1.8. Key Developments
    • 20.1.9. SWOT Analysis
  • 20.2. Ferring Pharmaceuticals
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. SWOT Analysis
  • 20.3. Fidia Farmaceutici
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Product Segmentation
    • 20.3.4. Recent Developments
    • 20.3.5. SWOT Analysis
  • 20.4. Sanofi
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation by Revenue 2013
    • 20.4.4. Business Segmentation by Revenue 2012 and 2013
    • 20.4.5. Geographical Segmentation by Revenue 2013
    • 20.4.6. Business Strategy
    • 20.4.7. Key Developments
    • 20.4.8. SWOT Analysis
  • 20.5. Seikagaku
    • 20.5.1. Key Facts
    • 20.5.2. Business Overview
    • 20.5.3. Business Segmentation by Revenue 2013
    • 20.5.4. Business Segmentation by Revenue 2012 and 2013
    • 20.5.5. Business Strategy
    • 20.5.6. SWOT Analysis

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: HA Production Process
  • Exhibit 3: Global HA Market Segmentation
  • Exhibit 4: Global HA Market Segmentation by Application
  • Exhibit 5: Global HA Market Segmentation by Product
  • Exhibit 6: Global HA Market Segmentation by Geography
  • Exhibit 7: Global HA Market 2013-2018 (US$ billion)
  • Exhibit 8: Global HA Market Segmentation by Application 2013-2018
  • Exhibit 9: Global HA Market Segmentation by Application 2013-2018 (Consolidated)
  • Exhibit 10: Global HA Market in Dermal Fillers 2013-2018 (US$ billion)
  • Exhibit 11: Global HA Market for Osteoarthritis 2013-2018 (US$ billion)
  • Exhibit 12: Global HA Market in VUR 2013-2018 (US$ billion)
  • Exhibit 13: Global HA Market in Ophthalmic 2013-2018 (US$ billion)
  • Exhibit 14: Global HA Market Segmentation by Product 2013-2018
  • Exhibit 15: Global HA Market Segmentation by Product 2013-2018 (Consolidated)
  • Exhibit 16: Global Single-Injection Cycle HA Products Market 2013-2018 (US$ billion)
  • Exhibit 17: Global Three-Injection Cycle HA Products Market 2013-2018 (US$ billion)
  • Exhibit 18: Global Five-Injection Cycle HA Products Market 2013-2018 (US$ billion)
  • Exhibit 19: Global HA Market Segmentation by Geography 2013-2018
  • Exhibit 20: Global HA Market Segmentation by Geography 2013-2018 (Consolidated)
  • Exhibit 21: HA Market in North America 2013-2018 (US$ billion)
  • Exhibit 22: HA Market in Europe 2013-2018 (US$ billion)
  • Exhibit 23: HA Market in the APAC Region 2013-2018 (US$ billion)
  • Exhibit 24: HA Market in ROW 2013-2018 (US$ billion)
  • Exhibit 25: Aging Population Above 60 and its Growth Rate 1995-2050 (in millions)
  • Exhibit 26: Allergan Inc.: Business Segmentation
  • Exhibit 27: Allergan Inc.: Revenue by Business Segmentation 2013
  • Exhibit 28: Allergan Inc.: Revenue Comparison by Business Segmentation 2011-2013 (US$ billion)
  • Exhibit 29: Allergan Inc.: Revenue by Geographical Segmentation 2013
  • Exhibit 30: Fidia Farmaceutici : Product Segmentation 2013
  • Exhibit 31: Sanofi: Business Segmentation by Revenue 2013
  • Exhibit 32: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 33: Sanofi: Geographical Segmentation by Revenue 2013
  • Exhibit 34: Seikagaku: Business Segmentation by Revenue 2013
  • Exhibit 35: Seikagaku: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Back to Top